Skip to content
10-K

Annual Report

Connect Biopharma Holdings Ltd CNTB

0001835268-26-000013

← back to feed
Filed
Mar 31, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 26, 2026 56.52M sh
Shares Diluted FY 2025 · Dec 31, 2025 55.66M sh
Shares Diluted FY 2025 · Dec 31, 2024 55.21M sh
Capex FY 2025 · Dec 31, 2025 $434K
Capex FY 2025 · Dec 31, 2024 $750K
Operating Cash Flow FY 2025 · Dec 31, 2025 −$51.21M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$23.61M
Short Term Investments FY 2025 · Dec 31, 2025 $6M
Short Term Investments FY 2025 · Dec 31, 2024 $15.48M
Cash And Equivalents FY 2025 · Dec 31, 2025 $38.35M
Cash And Equivalents FY 2025 · Dec 31, 2024 $78.23M
Stockholders Equity FY 2025 · Dec 31, 2025 $41.98M
Stockholders Equity FY 2025 · Dec 31, 2024 $92.17M
Stockholders Equity FY 2025 · Dec 31, 2023 $101.5M
Current Liabilities FY 2025 · Dec 31, 2025 $13.61M
Current Liabilities FY 2025 · Dec 31, 2024 $8.46M
Total Liabilities FY 2025 · Dec 31, 2025 $14.1M
Total Liabilities FY 2025 · Dec 31, 2024 $9.12M
Current Assets FY 2025 · Dec 31, 2025 $50.93M
Current Assets FY 2025 · Dec 31, 2024 $96.96M
Total Assets FY 2025 · Dec 31, 2025 $56.08M
Total Assets FY 2025 · Dec 31, 2024 $101.28M
Eps Diluted FY 2025 · Dec 31, 2025 −$1.00
Eps Diluted FY 2025 · Dec 31, 2024 −$0.28
Eps Basic FY 2025 · Dec 31, 2025 −$1.00
Eps Basic FY 2025 · Dec 31, 2024 −$0.28
Sga Expense FY 2025 · Dec 31, 2025 $20.34M
Sga Expense FY 2025 · Dec 31, 2024 $19.23M
Rd Expense FY 2025 · Dec 31, 2025 $37.8M
Rd Expense FY 2025 · Dec 31, 2024 $29.26M
Net Income FY 2025 · Dec 31, 2025 −$55.48M
Net Income FY 2025 · Dec 31, 2024 −$15.63M
Operating Income FY 2025 · Dec 31, 2025 −$58.07M
Operating Income FY 2025 · Dec 31, 2024 −$22.45M
Revenue FY 2025 · Dec 31, 2025 $64K
Revenue FY 2025 · Dec 31, 2024 $26.03M